Floor Heubel-Moenen

Post doc

Dr. Floor Heubel-Moenen is an internist-haematologist and haemophilia practitioner and assistant professor at Maastricht University Medical Center+ (MUMC+), a recognized expert centre for haemophilia, von Willebrand disease, and platelet function disorders. She obtained her PhD in 2022 with a thesis on “Diagnostics and mechanisms of haemostasis in patients with mild bleeding disorders and thrombocytopenia.”

She has since established a national research line on bleeding disorders of unknown cause (BDUC), integrating clinical phenotyping, advanced haemostasis diagnostics, and patient-centred outcomes within the multicentre BDUC-iN study. Her work focuses on improving diagnostic yield and enabling mechanism-based care through innovative haemostasis assays, including the Maastricht Flow Chamber, which she pioneered for application in BDUC diagnostics.

In recognition of her leadership in translating novel diagnostics into clinical practice, she was awarded the Translate2Clinic Fellowship (2023), providing dedicated research time and funding for a PhD position. In 2026, she received funding from the Academic Fund MUMC+ to further expand the BDUC-iN study. She was also awarded the ISTH Clair McLintock Award for her research on haemostasis in menstrual blood.

Dr. Heubel-Moenen is actively involved in education and supervision, teaching in national courses on transfusion medicine and haemostasis, clinical chemistry training programmes, PhD education and Medical curriculum. She supervises multiple PhD candidates as well as bachelor’s and master’s students.

At the national level, she serves as board member of the Dutch Society of Haematology (NVVH) and chairs the Dutch guideline committee on bleeding evaluation. She is also associate editor of Research and Practice in Thrombosis and Haemostasis (RPTH).

Internationally, she is an active member of the ISTH Scientific Subcommittee on von Willebrand Factor, contributing to the definition and recognition of BDUC and (co-)chairing the ISTH-SSC joint sessions on BDUC. She is a frequently invited speaker at international conferences, including the European Hematology Association (EHA), EAHAD, ISTH SSC meetings, and the Åland Island Meeting on von Willebrand Disease.

Beyond her clinical and research activities, she is engaged in regional fundraising initiatives, including the project “Bloedtesten door dik en dun” for the Health Foundation Limburg. Her work is driven by a strong commitment to multidisciplinary collaboration between clinicians, laboratory specialists, fundamental scientists, and patients, as the foundation for innovation and excellence in bleeding disorder care.

Department of Internal Medicine - Hematology
Maastricht UMC+, P. Debyelaan 25, 6229 HX Maastricht
T: +31(0)43 387 7976

2026
- van der Zwet, K., de Vos, A. D. W., Cnossen, M. H., Heubel-Moenen, F. C. J. I., Schols, S. E. M., Ypma, P. F., den Exter, P. L., Hooimeijer, H. L., Coppens, M., Mathôt, R. A. A., Janssen, A., Donners, A. A. M. T., Kruis, I., Urbanus, R. T., van Vulpen, L. F. D., Eckhardt, C. L., Schutgens, R. E. G., Fischer, K., Cnossen, M. H., ... Schutgens, R. E. G. (2026). Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study. Journal of Thrombosis and Haemostasis, 24(3), 890-899. https://doi.org/10.1016/j.jtha.2025.10.029
- Halkes, C. J. M., Koster, E. A. S., Bogers, E. J. M., Heubel-Moenen, F. C. J. I., Daenen, L. G. M., Klein, S. K., Langemeijer, S. M. C., Nur, E., Raaijmakers, M. H. G., Snijders, T. J. F., Tjon, J. M. L., & De Wreede, L. C. (2026). Anti-thymocyte globulin-based treatment frequently leads to enduring treatment success in both old and young adult patients with aplastic anaemia: a real-world analysis from the Dutch aplastic anaemia registry. Annals of Hematology, 105(2), Article 51. https://doi.org/10.1007/s00277-026-06743-5
- de Vaan, A., Eikenboom, J., Kruip, M., Punt, M., Schols, S., Heubel-Moenen, F., Coppens, M., Nieuwenhuizen, L., Mäkelburg, A., Peters, M., Duvekot, H., Middeldorp, A., Bloemenkamp, K., Schutgens, R., Lely, T., & van Galen, K. (2026). Higher-dosed clotting factor prophylaxis fails to reduce postpartum hemorrhage in women with von Willebrand disease: findings from the observational PRegnancy and Inherited bleeding DisordErS study. Journal of Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1016/j.jtha.2025.11.038
2025
- Monard, A. L. L., Hellenbrand, D., Verhezen, P., Beckers, E. A. M., Henskens, Y. C. M., & Heubel-Moenen, F. C. J. I. (2025). tPA-ROTEM identifies hyperfibrinolytic profile in a significant proportion of patients with bleeding disorder of unknown cause (BDUC). Thrombosis Research, 253, Article 109404. https://doi.org/10.1016/j.thromres.2025.109404
- Atiq, F., Blok, R., van Kwawegen, C., Hulshof, A.-M., Doherty, D., Lavin, M., van der Bom, J. G., O'Connell, N. M., de Meris, J., Ryan, K., Schols, S. E. M., van Heerde, W. L., Doyle, M. M., Byrne, M. B., Heubel-Moenen, F. C. J. I., van Galen, K. P. M., Preston, R. J. S., Cnossen, M. H., Fijnvandraat, K., ... O'Donnell, J. S. (2025). Clinical phenotype and pathophysiological mechanisms underlying qualitative Low VWF. Blood, 146(3), 369-381. https://doi.org/10.1182/blood.2024028035
- Monard, A., Henskens, Y., & Heubel-Moenen, F. (2025). The diagnostic value of the platelet function analyzer in mild to moderate bleeding disorders. Journal of Thrombosis and Haemostasis, 23(7), 2116-2118. https://doi.org/10.1016/j.jtha.2025.03.041
- Mussert, C. M. A., Monard, A. L. L., van Duijl, T. T., Henskens, Y. M. C., van den Biggelaar, M., Schutgens, R. E. G., Schols, S. E. M., Fijnvandraat, K. J., Meijer, K., den Exter, P. L., Nieuwenhuizen, L., van Moort, I., Kruip, M. J. H. A., Cnossen, M. H., Heubel-Moenen, F. C. J. I., & BDUC-iN Study group (2025). Current Practice Regarding Bleeding Disorders of Unknown Cause in the Netherlands: A National Survey. Haemophilia, 31(4), 752-760. https://doi.org/10.1111/hae.70065
- Mansouritorghabeh, H., Monard, A., Heubel-Moenen, F., Leentjens, J., Stroobants, A., & Henskens, Y. (2025). The Utility of Total Thrombus-Formation Analysis System (T-TAS) in the Thrombosis and Hemostasis Field: A Scoping Review. International Journal of Laboratory Hematology, 47(2), 201-211. https://doi.org/10.1111/ijlh.14403
- van Kwawegen, C. B., Pastoor, H., Eikenboom, J., Fijnvandraat, K., Ypma, P., Heubel-Moenen, F. C. J. I., van Galen, K. P. M., Mauser-Bunschoten, E. P., Meijer, K., Schols, S. E. M., Cnossen, M. H., van der Bom, J. G., de Meris, J., Atiq, F., Kruip, M. J. H. A., Leebeek, F. W. G., & WiN Study Group (2025). Sexuality and bleeding in von Willebrand disease. Research and practice in thrombosis and haemostasis, 9(2), Article e102712. https://doi.org/10.1016/j.rpth.2025.102712
2024
- Jooss, N. J., Diender, M. G., Fernandez, D. I., Huang, J., Heubel-Moenen, F. C. J., van der Veer, A., Kuijpers, M. J. E., Poulter, N. S., Henskens, Y. M. C., te Loo, M., & Heemskerk, J. W. M. (2024). Restraining of glycoprotein VI- and integrin α2β1-dependent thrombus formation by platelet PECAM1. Cellular and Molecular Life Sciences, 81(1), Article 44. https://doi.org/10.1007/s00018-023-05058-2
- Monard, A. L. L., Mussert, C. M. A., van Duijl, T. T., Kruip, M. J. H. A., Henskens, Y. M. C., van den Biggelaar, M., Schutgens, R. E. G., Schols, S. E. M., Fijnvandraat, K. J., Meijer, K., den Exter, P. L., Nieuwenhuizen, L., van Moort, I., Baker, R. I., O'Donnell, J. S., Cnossen, M. H., Heubel-Moenen, F. C. J. I., & BDUC-iN Study group (2024). Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives. Research and practice in thrombosis and haemostasis, 8(8), Article 102625. https://doi.org/10.1016/j.rpth.2024.102625
- Monard, A., Castoldi, E., De Simone, I., Wichapong, K., van Duijl, T., van den Biggelaar, M., Spada, S., van Doorn, W., Hellenbrand, D., van der Meijden, P., Swieringa, F., Stork, A., ten Cate, H., Beckers, E., Heubel-Moenen, F., & Henskens, Y. (2024). Case Report: Laboratory detection of a thrombotic tendency in a family with hypodysfibrinogenemia and a novel FGG mutation. Frontiers in Cardiovascular Medicine, 11, Article 1488602. https://doi.org/10.3389/fcvm.2024.1488602
- Mussert, C., Monard, A., & Heubel-Moenen, F. (2024). How to treat patients with bleeding disorder of unknown cause?Research and practice in thrombosis and haemostasis, 8(7), Article 102585. https://doi.org/10.1016/j.rpth.2024.102585
- Haisma, B., Schols, S. E. M., van Oerle, R. G. M., Verbeek-Knobbe, K., Hellenbrand, D., Verwoerd, E. J., Heubel-Moenen, F. C. J. I., Stroobants, A. K., Meijer, D., Rijpma, S. R., & Henskens, Y. M. C. (2024). Comparative analysis of thrombin generation platforms for patients with coagulation factor deficiencies: A comprehensive assessment. Thrombosis Research, 240, Article 109045. https://doi.org/10.1016/j.thromres.2024.109045
- Punt, M., van Leusden, F., Bloemenkamp, K., Coppens, M., Driessens, M., Heubel-Moenen, F., Lely, T., Mäkelburg, A., Nieuwenhuizen, L., Haitjema, S., van Solinge, W., Saes, J., Schols, S., Schutgens, R., Eikenboom, J., Kruip, M., & van Galen, K. (2024). Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysis. Research and practice in thrombosis and haemostasis, 8(5), Article 102508. https://doi.org/10.1016/j.rpth.2024.102508
- Baker, R. I., Choi, P., Curry, N., Gebhart, J., Gomez, K., Henskens, Y., Heubel-Moenen, F., James, P., Abdul Kadir, R., Kouides, P., Lavin, M., Lordkipanidze, M., Lowe, G., Mumford, A., Mutch, N., Nagler, M., Othman, M., Pabinger, I., Sidonio, R., ... ISTH SSC Von Willebrand Factor, Platelet Physiology and Women’s Health Issues in Thrombosis and Haemostasis. (2024). Standardization of definition and management for bleeding disorder of unknown cause: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 22(7), 2059-2070. https://doi.org/10.1016/j.jtha.2024.03.005
- Monard, A., Thomas, W., & Heubel-Moenen, F. (2024). Bleeding disorders of unknown cause; the role of physiological anticoagulants. Thrombosis Research, 237, 216-217. https://doi.org/10.1016/j.thromres.2024.02.025
- Atiq, F., Blok, R., van Kwawegen, C., Doherty, D., Lavin, M., van der Bom, J. G., O'Connell, N. M., de Meris, J., Ryan, K., Schols, S. E. M., Byrne, M. B., Heubel-Moenen, F. C. J. I., van Galen, K. P. M., Preston, R. J. S., Cnossen, M. H., Fijnvandraat, K., Baker, R. I., Meijer, K., James, P. D., ... O'Donnell, J. S. (2024). Type 1 VWD classification revisited - novel insights from combined analysis of the LoVIC and WiN studies. Blood, 143(14), 1414-1424. https://doi.org/10.1182/blood.2023022457
- Goedhart, T. M. H. J., Bukkems, L. H., Zwagemaker, A. F., Coppens, M., Fijnvandraat, K., Schols, S. E. M., Schutgens, R. E. G., Eikenboom, J., Heubel-Moenen, F. C. J. I., Ypma, P. F., Nieuwenhuizen, L., Meijer, K., Leebeek, F. W. G., Mathôt, R. A. A., Cnossen, M. H., & OPTI-CLOT study group and SYMPHONY consortium (2024). Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B. Research and practice in thrombosis and haemostasis, 8(3), Article 102397. https://doi.org/10.1016/j.rpth.2024.102397
- Romano, L. G. R., Schütte, L. M., van Hest, R. M., Meijer, K., Laros-van Gorkom, B. A. P., Nieuwenhuizen, L., Eikenboom, J., Heubel-Moenen, F. C. J. I., Uitslager, N., Coppens, M., Fijnvandraat, K., Driessens, M. H. E., Polinder, S., Cnossen, M. H., Leebeek, F. W. G., Mathôt, R. A. A., Kruip, M. J. H. A., & DAVID and SYMPHONY Consortium (2024). Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practice. Research and practice in thrombosis and haemostasis, 8(3), Article 102367. https://doi.org/10.1016/j.rpth.2024.102367
- Romano, L. G. R., Schutte, L. M., van Hest, R. M., Meijer, K., Laros-van Gorkom, B. A. P., Nieuwenhuizen, L., Eikenboom, J., Heubel-Moenen, F. C. J. I., Uitslager, N., Coppens, M., Fijnvandraat, K., Driessens, M. H. E., Polinder, S., Cnossen, M. H., Leebeek, F. W. G., Mathot, R. A. A., Kruip, M. J. H. A., & DAVID SYMPHONY Consortium (2024). Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patients. Haemophilia, 30(2), 355-366. https://doi.org/10.1111/hae.14946
2023
- Van de Berg, T. W., Beckers, E. A. M., Heubel-Moenen, F. C. J. I., Henskens, Y. M. C., Thomassen, M. C. L. G. D., & Hackeng, T. M. (2023). Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa. Thrombosis and Haemostasis, 123(11), 1034-1041. https://doi.org/10.1055/a-2101-7961
- Brands, M. R., Janssen, E. A. M., Cnossen, M. H., Smit, C., van Vulpen, L. F. D., van der Valk, P. R., Eikenboom, J., Heubel-Moenen, F. C. J. I., Hooimeijer, L., Ypma, P., Nieuwenhuizen, L., Coppens, M., Schols, S. E. M., Laros-van Gorkom, B. A. P., Leebeek, F. W. G., Driessens, M. H. E., Rosendaal, F. R., van der Bom, J. G., Fijnvandraat, K., & Gouw, S. C. (2023). Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study. Haemophilia, 29(5), 1191-1201. https://doi.org/10.1111/hae.14834
- Romano, L. G. R., van Vulpen, L. F. D., den Exter, P. L., Heubel-Moenen, F. C. J. I., Hooijmeijer, H. L., Coppens, M., Fijnvandraat, K., Schols, S. E. M., Ypma, P. F., Smit, C., Driessens, M. H. E., Md, F. R. R., van der Bom, J. G., Gouw, S. C., & Kruip, M. J. H. A. (2023). Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy. Research and practice in thrombosis and haemostasis, 7(5), Article 100281. https://doi.org/10.1016/j.rpth.2023.100281
- Schaap, C. C. M., Heubel-Moenen, F. C. J. I., Nur, E., Bartels, M., van der Heijden, O. W. H., de Jonge, E., Preijers, F. W. M. B., Blijlevens, N. M. A., Langemeijer, S. M. C., & Dutch PNH Working Group (2023). Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes. European Journal of Haematology, 110(6), 648-658. https://doi.org/10.1111/ejh.13946
- Kempers, E. K., van Kwawegen, C. B., de Meris, J., Spaander, M. C. W., Schols, S. E. M., Ypma, P. F., Heubel-Moenen, F. C. J. I., van Vulpen, L. F. D., Coppens, M., van der Bom, J. G., Fijnvandraat, K., Meijer, K., Eikenboom, J., Gouw, S. C., Leebeek, F. W. G., & Kruip, M. J. H. A. (2023). Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients. Journal of Thrombosis and Haemostasis, 21(5), 1177-1188. https://doi.org/10.1016/j.jtha.2022.12.004
- Heubel-Moenen, F. C. J. I., Ansems, L. E. M., Verhezen, P. W. M., Wetzels, R. J. H., van Oerle, R. G. M., Straat, R. J. M. H. E., Megy, K., Downes, K., Henskens, Y. M. C., Beckers, E. A. M., & Joore, M. A. (2023). Effectiveness and costs of a stepwise versus an all-in-one approach to diagnose mild bleeding disorders. British Journal of Haematology, 200(6), 792-801. https://doi.org/10.1111/bjh.18570
2022
- Veninga, A., Handtke, S., Aurich, K., Tullemans, B., Brouns, S., Schwarz, S. L., Heubel-Moenen, F. C., Greinacher, A., Heemskerk, J. W. M., van der Meijden, P., & Thiele, T. (2022). GPVI expression is linked to platelet size, age, and reactivity. Blood advances, 6(14), 4162-4173. https://doi.org/10.1182/bloodadvances.2021006904
- Heubel-Moenen, F. C. J. I., Brouns, S. L. N., Herfs, L., Boerenkamp, L. S., Jooss, N. J., Wetzels, R. J. H., Verhezen, P. W. M., Machiels, P., Megy, K., Downes, K., Heemskerk, J. W. M., Beckers, E. A. M., & Henskens, Y. M. C. (2022). Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time. British Journal of Haematology, 196(6), 1388-1400. https://doi.org/10.1111/bjh.18003
- Post, D. S., van der Veer, A., Schijns, O. E. M. G., Klinkenberg, S., Rijkers, K., Wagner, G. L., van Kranen-Mastenbroek, V. H. J. M., Willems, P. C. P. H., Verhezen, P. W. M., Beckers, E. A. M., Heubel-Moenen, F. C. J. I., & Henskens, Y. M. C. (2022). Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study. PLOS ONE, 17(2), Article e0264351. https://doi.org/10.1371/journal.pone.0264351
- Goedhart, T. M. H. J., Bukkems, L. H., Coppens, M., Fijnvandraat, K. J., Schols, S. E. M., Schutgens, R. E. G., Eikenboom, J., Heubel-Moenen, F. C. J. I., Ypma, P. F., Nieuwenhuizen, L., Meijer, K., Leebeek, F. W. G., Mathôt, R. A. A., & Cnossen, M. H. (2022). Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study). TH open : companion journal to thrombosis and haemostasis, 6(1), e60-e69. https://doi.org/10.1055/a-1760-0105
2021
- Herfs, L., Swieringa, F., Jooss, N., Kozlowski, M., Heubel-Moenen, F. C. J., van Oerle, R., Machiels, P., Henskens, Y., & Heemskerk, J. W. M. (2021). Multiparameter microfluidics assay of thrombus formation reveals increased sensitivity to contraction and antiplatelet agents at physiological temperature. Thrombosis Research, 203, 46-56. https://doi.org/10.1016/j.thromres.2021.04.014
- Bukkems, L. H., Heijdra, J. M., de Jager, N. C. B., Hazendonk, H. C. A. M., Fijnvandraat, K., Meijer, K., Eikenboom, J. C. J., Laros-Van Gorkom, B. A. P., Leebeek, F. W. G., Cnossen, M. H., Mathôt, R. A. A., Coppens, K. F. M., Kruip, M. J. H. A., Polinder, S., Lock, J., Hazendonk, H. C. A. M., van Moort, I., Heijdra, J. M., Goedhart, M. C. H. J., ... OPTI-CLOT Study Group (2021). Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease. Blood advances, 5(5), 1513-1522. https://doi.org/10.1182/BLOODADVANCES.2020003891
- Perrella, G., Huang, J., Provenzale, I., Swieringa, F., Heubel-Moenen, F. C. J., Farndale, R. W., Roest, M., van der Meijden, P. E. J., Thomas, M., Ariens, R. A. S., Jandrot-Perrus, M., Watson, S. P., & Heemskerk, J. W. M. (2021). Nonredundant Roles of Platelet Glycoprotein VI and Integrin αIIbβ3 in Fibrin-Mediated Microthrombus Formation. Arteriosclerosis Thrombosis and Vascular Biology, 41(2), E97-E111. https://doi.org/10.1161/ATVBAHA.120.314641
2020
- van Lier, Y. F., Davids, M., Haverkate, N. J. E., de Groot, P. F., Donker, M. L., Meijer, E., Heubel-Moenen, F. C. J. I., Nur, E., Zeerleder, S. S., Nieuwdorp, M., Blom, B., & Hazenberg, M. D. (2020). Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients. Science Translational Medicine, 12(556), Article 8926. https://doi.org/10.1126/scitranslmed.aaz8926
- Thaventhiran, J. E. D., Lango Allen, H., Burren, O. S., Rae, W., Greene, D., Staples, E., Zhang, Z., Farmery, J. H. R., Simeoni, I., Rivers, E., Maimaris, J., Penkett, C. J., Stephens, J., Deevi, S. V. V., Sanchis-Juan, A., Gleadall, N. S., Thomas, M. J., Sargur, R. B., Gordins, P., ... Smith, K. (2020). Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature, 584(7819), E2-E2. https://doi.org/10.1038/s41586-020-2556-6
- Thaventhiran, J. E. D., Allen, H. L., Burren, O. S., Rae, W., Greene, D., Staples, E., Zhang, Z., Farmery, J. H. R., Simeoni, I., Rivers, E., Maimaris, J., Penkett, C. J., Stephens, J., Deevi, S. V. V., Sanchis-Juan, A., Gleadall, N. S., Thomas, M. J., Sargur, R. B., Gordins, P., ... Smith, K. G. C. (2020). Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature, 583(7814), 90-95. https://doi.org/10.1038/s41586-020-2265-1
2019
- Heubel-Moenen, F. C. J. I., Henskens, Y. M. C., Verhezen, P. W. M., Wetzels, R. J. H., Schouten, H. C., & Beckers, E. A. M. (2019). Fibrinolysis in patients with chemotherapy-induced thrombocytopenia and the effect of platelet transfusion. Journal of Thrombosis and Haemostasis, 17(7), 1073-1084. https://doi.org/10.1111/jth.14465
- Moenen, F. C. J., Vries, M. J. A., Nelemans, P. J., van Rooy, K. J. M., Vranken, J. R. R. A., Verhezen, P. W. M., Wetzels, R. J. H., ten Cate, H., Schouten, H. C., Beckers, E. A. M., & Henskens, Y. M. C. (2019). Screening for platelet function disorders with Multiplate and platelet function analyzer. Platelets, 30(1), 81-87. https://doi.org/10.1080/09537104.2017.1371290
2018
- Baaten, C. C. F. M. J., Moenen, F. C. J. I., Henskens, Y. M. C., Swieringa, F., Wetzels, R. J. H., van Oerle, R., Heijnen, H. F. G., ten Cate, H., Holloway, G. P., Beckers, E. A. M., Heemskerk, J. W. M., & van der Meijden, P. E. J. (2018). Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy. Haematologica-the Hematology Journal, 103(9), 1557-1567. https://doi.org/10.3324/haematol.2017.185165
- Moenen, F. C. J. I., Nelemans, P. J., Schols, S. E. M., Schouten, H. C., Henskens, Y. M. C., & Beckers, E. A. M. (2018). The diagnostic accuracy of bleeding assessment tools for the identification of patients with mild bleeding disorders: A systematic review. Haemophilia, 24(4), 525-535. https://doi.org/10.1111/hae.13486
2016
- Baaten, C. C. F. M. J., Moenen, F. C. J. I., Henskens, Y. M. C., Swieringa, F., Wetzels, R., van Oerle, R., ten Cate, H., Beckers, E. A. M., Heemskerk, J. W. M., & van der Meijden, P. E. J. (2016). Multiple functional defects in platelets from thrombocytopenic cancer patients undergoing chemotherapy. Thrombosis Research, 140S1, S171-S171. https://doi.org/10.1016/s0049-3848(16)30125-6
- Moenen, F. C. J. I., Bakers, F. C. H., & Bos, G. (2016). Pancreatic atrophy after allogeneic peripheral blood stem cell transplantation. British Journal of Haematology, 172(2), 155-155. https://doi.org/10.1111/bjh.13643

Overview

Latest news & events

NWO Faculty of Impact grant awarded to Hongxing Luo

12 March 2026

Recap Anna Maria van Schurman Symposium 2026

11 March 2026

Floor Heubel-Moenen

Post doc